The incidence and prognosis of coronary slow-flow (CSF) and no-reflow phenomenon (NRP) in patients with coronary chronic total occlusion (CTO) who underwent percutaneous coronary intervention (PCI) remain unclear.
Introduction
Percutaneous coronary intervention (PCI) plays a crucial role in the management of coronary artery disease, especially in the setting of acute ST-elevation myocardial infarction (STEMI). However, even if complete revascularization is achieved, adequate reperfusion in the myocardium as demonstrated on angiography is not necessarily maintained. 1, 2 Previous studies showed that the prevalence of CSF/NRP in all patients who underwent PCI was 2-3.2%. [3] [4] [5] Studies also confirmed that CSF/NRP occurred in a significant proportion of patients with STEMI during emergency PCI with an incidence of 30-40%. [6] [7] [8] Increasing evidence has suggested that CSF/NRP is associated with PCI-related myocardial infarction, in-hospital mortality, and a poor prognosis. 4, 9, 10 CTO is defined as thrombolysis in myocardial infarction (TIMI) grade 0 flow with a 3-month duration documented angiographically or clinically defined. 11 Previous studies
showed that approximately 20% of patients with coronary heart disease have at least one vascular CTO lesion.
11
Accumulating evidence has confirmed that successful revascularization can effectively improve myocardial ischemia and relieve angina, 12 improve left ventricular function, 13 and improve clinical outcomes 14, 15 in patients with CTO. However, a higher risk of CTO-PCI, longer procedure duration, and larger number of implanted stents made it different from routine interventional therapy, and the incidence of CSF/NRP and its effects on prognosis remain unclear. This study sought to investigate the incidence of CSF/ NRP in patients with CTO who underwent PCI, determine the predictors of CSF/NRP, and assess its effects on patient outcomes.
Methods

Study Design and Patients
In this study, patients with a confirmed diagnosis of CTO were consecutively selected between January 2015 and May 2018 at our hospital. The exclusion criteria were as follows: current pregnancy; known allergy to aspirin, clopidogrel, or ticagrelor; refusal to accept interventional therapy or no stent implantation; life expectancy <1 year; and refusal to participate in the trial. CSF/NRP was defined as TIMI grade ≤2 by two experienced cardiologists (Ai-jie Hou and Bo Luan).A total of 552 patients were enrolled in the study, including 89 with CSF/NRP and 463 with normal blood flow (Figure 1 ).
The radial artery was the routine access point, but the physician determined the access as needed. During the procedure, a standard dose of unfractionated heparin 100 IU/kg was used as anticoagulant therapy, and unfractionated heparin 2000 IU was added every hour. The use of glycoprotein IIb/IIIa inhibitor (GPI) was left to the physician's discretion. The study was approved by the Institutional Review Board of the People's Hospital of Liaoning Province and complied with the Declaration of Helsinki. All patients signed informed consent before participation.
Study end points
The primary study end point was a composite of major cardiac and cerebrovascular events (MACCEs), including cardiac death, target vessel revascularization (TVR), stent thrombosis, nonfatal myocardial infarction (MI), PCIassociated MI (during the hospitalization period), and nonfatal stroke within 1 year of follow-up. MI was defined as the presence of pathological Q waves in at least two consecutive leads, or without a pathological Q wave, the markers of myocardial injury increased to more than twice the upper limit of normal but was not related to PCI or bypass. 16 PCI-related MI was defined as an elevated cardiac troponin T (cTn) value to more than five times the 99 th percentile of cTn level in patients with normal baseline values. 16 
Statistical Analysis
The graphs were used to assess survival without MACCEs. All tests were two-sided, and p values <0.05 were considered significant.
Results
A total of 552 CTO patients who underwent PCI were included in this study (Figure 1 Table 2 ). Age, female sex, smoking, body mass index, diabetes mellitus, hypertension, mean platelet volume (MPV), neutrophil ratio, platelet distribution width (PDW), LDL cholesterol (LDL-C), fasting glucose (FG), uric acid, Hs-CRP, retrograde filling of grade >2, and GPI were analyzed in univariate analysis. Diabetes mellitus, hypertension, MPV, neutrophil ratio, PDW, LDL-C, FG, Hs-CRP, and retrograde filling of grade >2 were included in the multivariate logistic regression analysis. Diabetes mellitus (odds ratio (Table 3) . 
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During the hospitalization period, the incidence of PCIrelated MI was significantly higher in the CSF/NRP group than in the non-CSF/NRP group (32.6% vs 14.9%, p<0.001), and the incidence of MACCEs was also significantly higher in the CSF/NRP group than in the non-CSF/NRP group (37.1% vs 18.6%, p<0.001). At 1-year follow-up, the incidences of TVR (22.0% vs 5.8%, p<0.001) and MACCE (47.2% vs 21.4%, p<0.001) were significantly higher in the CSF/NRP group than in the non-CSF/NRP group (Table 4) . KaplanMeier analysis revealed that the cumulative MACCE-free survival was significantly lower in the CSF/NRP group than in the non-CSF/NRP group (p<0.0001; Figure 2 ).
Discussion
This study was the first to investigate the incidence, predictive factors, and prognosis of CSF/NRP inpatients with CTO who successfully underwent PCI. The study confirmed that16.1% of patients with CTO who underwent PCI developed CSF, which had a significantly lower cumulative MACCE-free survival rate. Diabetes mellitus; higher MPV and levels of LDL-C, FG, and Hs-CRP; and a lower retrograde filling level (grade >2) were independent predictors of CSF/NRP in patients with CTO who underwent PCI. Thus, these factors can be used for risk stratification.
The etiology of CSF/NRP is complex and still not fully understood. Its possible mechanisms include endothelial dysfunction, microvascular ischemia and edema, embolization, and reperfusion injury. 17 Currently, the incidence of CSF/NRP varies widely among different study populations. Most of these studies were in STEMI patients. Some recent studies demonstrated that the proportion of NRP in all PCI patients was2-3.2%. [3] [4] [5] Studies also confirmed that CSF/NRP occurred at a prevalence of 30-40% in STEMI patients during emergency PCI. [6] [7] [8] The present study showed that the incidence of CSF/NRP in such patients was as high as 16.1%. We speculated that the guide wire may penetrate the proximal or distal fibrous cap during antegrade interventional therapy or the retrograde wire technique, causing the release of lipids from atherosclerotic plaques that may lead to the occlusion of distal blood vessels, especially micro vessels. Although many researchers have proposed several predictors of CSF/NRP, 18 their predictive value in different study populations requires further investigation. Studies have confirmed that >50% of patients with STEMI have abnormal glucose metabolism. Although early revascularization can achieve significant clinical results, patients with abnormal glucose metabolism have poorer microvascular perfusion and a higher risk of developing CSF/NRP. 19 The present study also found that diabetes mellitus and a high fasting blood glucose level are independent predictors of CSF/NRP as shown in previous studies. The present study demonstrated that a high LDL-C level is associated with CSF/NRP. Previous studies confirmed that hypercholesterolemia is associated with endothelial dysfunction because it reduces the bioavailability of vascular nitric oxide. 20 Pretreatment with statins effectively prevents CSF/NRP, 21 reduces the incidence of postoperative MI, 22 and improves myocardial perfusion after PCI. 23 These findings also indirectly confirm that hyperlipidemia is involved in the pathogenesis of CSF/NRP. Studies have shown that a higher inflammation status plays an important role in the development of CSF/NRP during emergency PCI for STEMI. 24 Oduncuet al 25 showed that patients with NRP have a higher baseline Hs-CRP level. The independent relationship between Hs-CRP and NRP development, which was discovered in this study, has also been reported previously. 26 The present study confirmed that MPV was significantly elevated in the CSF/ NRP group and is an independent predictor of CSF/NRP. We suggest that MPV is an indicator of platelet activation that plays an important role in the pathophysiology of cardiovascular disease; previous studies also confirmed its association with CSF/NRP. 18 We also found that patients with better collateral circulation had a lower incidence of CSF/NRP, presumably because the collateral circulation provides better myocardial perfusion to occluded vessels and its endothelial and microvascular functions are relatively less damaged; thus, the incidence of CSF/NRP is lower because reperfusion-related damage is less severe. CSF/NRP is clinically important, as increasing evidence has suggested that it is associated with PCI-related MI, inhospital mortality, and poor prognosis. 4, 9, 10 In addition,
Butler et al reported that transient CSF/NRP is even more common than persistent CSF/NRP and results in significantly increased 30-day morbidity and mortality rates. 27 Our study found that CTO-PCI patients with CSF/NRPs had significantly increased incidences of perioperative MI, MACCEs during hospitalization and the 1-year follow-up period, and TVRat1-year follow-up. Their MACCE-free survival rate was significantly lower than that of non-CSF/NRP patients. The CSF/NRP condition of CTO-PCI patients warrants additional attention due to its unique pathophysiology and complex interventional procedures. We recommend that these conditions be identified separately from acute MI. As this was a small-sample single-center study, some bias exists. In the future, a large-sample multicenter prospective randomized controlled trial is needed to validate our conclusions.
Conclusion
Of the patients with CTO who underwent PCI, 16.1% developed CSF/NRP and had a significantly lower cumulative MACCE-free survival rate. Diabetes mellitus; higher MPV, LDL-C, FG, and Hs-CRP levels; and a lower incidence of retrograde filling grade >2 were independent predictors of CSF/NRP in CTO patients who underwent PCI. Thus, these factors can be used for risk stratification.
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